N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide

C39H69N3O8 — CID 172946493

IUPACN-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide
SMILESC#CCCCC1(CCCCCCCCC(=O)N[C@H](CO[C@@H]2OC(CO)[C@@H](O)C(O)[C@@H]2O)[C@@H](O)/C=C/CCCCCCCCCCCCC)N=N1
InChIInChI=1S/C39H69N3O8/c1-3-5-7-8-9-10-11-12-13-14-15-18-21-25-32(44)31(30-49-38-37(48)36(47)35(46)33(29-43)50-38)40-34(45)26-22-19-16-17-20-24-28-39(41-42-39)27-23-6-4-2/h2,21,25,31-33,35-38,43-44,46-48H,3,5-20,22-24,26-30H2,1H3,(H,40,45)/b25-21+/t31-,32+,33?,35-,36?,37+,38-/m1/s1
InChIKeyGQEQPMYLTJEVQU-WZNCYSACSA-N
MW707.99 g/mol
LogP5.99
Rot. Bonds31

About N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide

N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide (PubChem CID 172946493) has the molecular formula C39H69N3O8 and a molecular weight of 707.99 g/mol. Its IUPAC name is N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide.

Molecular Properties

Compound NameN-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide
PubChem CID172946493
Molecular FormulaC39H69N3O8
Molecular Weight707.99 g/mol
Exact Mass707.51
IUPAC NameN-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide
SMILESC#CCCCC1(CCCCCCCCC(=O)N[C@H](CO[C@@H]2OC(CO)[C@@H](O)C(O)[C@@H]2O)[C@@H](O)/C=C/CCCCCCCCCCCCC)N=N1
InChIInChI=1S/C39H69N3O8/c1-3-5-7-8-9-10-11-12-13-14-15-18-21-25-32(44)31(30-49-38-37(48)36(47)35(46)33(29-43)50-38)40-34(45)26-22-19-16-17-20-24-28-39(41-42-39)27-23-6-4-2/h2,21,25,31-33,35-38,43-44,46-48H,3,5-20,22-24,26-30H2,1H3,(H,40,45)/b25-21+/t31-,32+,33?,35-,36?,37+,38-/m1/s1
InChIKeyGQEQPMYLTJEVQU-WZNCYSACSA-N
XLogP5.99
TPSA173.43 Ų
H-Bond Donors6
H-Bond Acceptors10
Rotatable Bonds31
Heavy Atoms50
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500707.99
LogP ≤ 55.99
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide?
The IUPAC name of N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide (CID 172946493) is N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide.
What is the SMILES notation for N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide?
The canonical SMILES for N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide is C#CCCCC1(CCCCCCCCC(=O)N[C@H](CO[C@@H]2OC(CO)[C@@H](O)C(O)[C@@H]2O)[C@@H](O)/C=C/CCCCCCCCCCCCC)N=N1.
What is the InChIKey of N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide?
The InChIKey is GQEQPMYLTJEVQU-WZNCYSACSA-N. The full InChI is InChI=1S/C39H69N3O8/c1-3-5-7-8-9-10-11-12-13-14-15-18-21-25-32(44)31(30-49-38-37(48)36(47)35(46)33(29-43)50-38)40-34(45)26-22-19-16-17-20-24-28-39(41-42-39)27-23-6-4-2/h2,21,25,31-33,35-38,43-44,46-48H,3,5-20,22-24,26-30H2,1H3,(H,40,45)/b25-21+/t31-,32+,33?,35-,36?,37+,38-/m1/s1.
What are the key properties of N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide?
N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide has a molecular weight of 707.99 g/mol, XLogP of 5.99, 31 rotatable bonds, 6 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(E,2R,3S)-3-hydroxy-1-[(2R,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide is sourced from PubChem (CID 172946493), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).